Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
UNAIDS warns funding cuts imperil HIV progress; new injectable offers limited hope unless scaled
Summary
On World AIDS Day, the director of UNAIDS’ New York office warned that major reductions in external health aid threaten prior gains against HIV and said a new twice-yearly injectable, lenacapavir, is being rolled out to 2 million people but must scale to tens of millions to change the epidemic’s course.
On World AIDS Day, Cesar Nunez, director of the UNAIDS New York office, warned that "the HIV epidemic is not over" and that recent declines in external health assistance threaten gains made in prevention and treatment.
In a briefing announcing UNAIDS’ new report, "Overcoming disruption, transforming the AIDS response," Nunez said OECD projections show external health aid could fall "30 to 40% in 2025 compared to 2023," and that those reductions are already causing "immediate and severe disruption to health services in low and middle income countries." He cited UNAIDS analysis that, under current trends, roughly 1,400,000 additional annual new HIV infections could occur by 2030 and about 3,900,000 excess new infections by 2030 compared with an end-of-AIDS pathway.
N…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
